Management of coronary artery disease: therapeutic options in patients with diabetes
- 27 July 2000
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (2) , 355-365
- https://doi.org/10.1016/s0735-1097(00)00732-4
Abstract
No abstract availableThis publication has 112 references indexed in Scilit:
- Diabetic dyslipidemiaThe American Journal of Cardiology, 1998
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trialThe American Journal of Cardiology, 1998
- Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery diseaseThe American Journal of Cardiology, 1996
- Carotid Artery Wall Intima-Media Thickness Is Associated With Insulin-Mediated Glucose Disposal in Men at High and Low Coronary RiskStroke, 1995
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995
- Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with anglographically demonstrated coronary artery diseaseThe American Journal of Cardiology, 1993
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986
- Lipids, diabetes, and coronary heart disease: Insights from the Framingham StudyAmerican Heart Journal, 1985